1 year return (CAGR)
-71.78%
Propanc Biopharma, Inc. Common Stock Exchange (NASDAQ, USD)
PPCB
0.64
-0.18 (-22.56%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-94.39%
5 year return (CAGR)
-94.98%
10 year return (CAGR)
-88.84%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.45M
Price/Sales
48.38
Ent value
5.51M
Price/Book
0.15
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
-22.64%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-85.28%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.84 |
| Daily high | 0.86 |
| Daily low | 0.63 |
| Daily Volume | 1.03M |
| All-time high | 999999999900.00 |
| 1y analyst estimate | 1.52 |
| Beta | 3.33 |
| EPS (TTM) | -20.47 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| PPCB | S&P500 | |
| Current price drop from All-time high | -100.00% | -3.06% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 16 Sep 2026 | 9 Mar 2009 |
| Avg drop from high | -84.28% | -10.68% |
| Avg time to new high | 8 days | 12 days |
| Max time to new high | 2340 days | 1805 days |
News
